Limbrel – Primus Pharmaceutical Company
Primus Pharmaceutical company has been warned by the Food and Drunk Administration to to pull the drug product, Limbrel, off the shelves due to the fact that it has been shown to cause lung and liver injury. Limbrel is marketed as a “medical food”, used to treat the metabolic processes linked with osteoarthritis. Primus stands by the drug’s claim that it helps improve mobility for patients suffering from osteoarthritis. The FDA made a claim back in December 2017 that they consider Limbrel to be an unapproved drug given the side effects.
Because a recall cannot be executed, the FDA has taken it upon itself and began patients currently taking Limbrel to extinguish use immediately. Almost 200 events including adverse side effects were reported while taking the drug. Patients suffering from liver injury report symptoms of nausea, excessive fatigue and jaundice. Fevers and intense coughing are reported by patients with hypersensitive pneumonitis.
The FDA released a statement saying. “The U.S. Food and Drug Administration is advising consumers not to use Limbrel, a product in capsule form currently being manufactured as a medical food to manage the metabolic processes associated with osteoarthritis. If you are currently using it, stop taking it immediately and contact your health care provider.”
Primus has been asked for since late 2017 to remove the product from sale. As of January 30th 2018, Primus has recalled all unexpired lots of Limbrel products.
If you or someone you love is suffering from the side effects associated with taking Limbrel, please contact the attorneys at Alonso Krangle LLP at 800-403-6191 our through our website at www.fightforvictims.com. Our attorneys specialize in product liability claims and will assist you in receiving the justice you deserve.
Please call us today to set up a consultation and review your legal rights.